Akron Pharma, Inc. FDA Record
- Latest inspection NAI · Aug 12, 2025
- No warning letters matched by name
Akron Pharma, Inc. has 11 FDA recalls, 1 inspection, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Akron Pharma, Inc." is on file.
- Latest recall
- D-0194-2025 · Class III · Dec 12, 2024
- Latest inspection
- Aug 12, 2025 · NAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 11 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 1 | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Akron Pharma, Inc.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 1 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 8 | 0 |
| 2023 | 0 | 0 | 0 | 1 | 0 |
| 2022 | 0 | 0 | 0 | 2 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing Akron Pharma, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Akron Pharma, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0194-2025 | Class III | Acetaminophen Regular Strength, 325 mg, 100 Tablets per bottle, Akron Pharma, Inc., 373 RT US 46 W… | Dec 12, 2024 |
| D-0198-2025 | Class III | Diphenhydramine HCl 25 mg, 1000 Capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma… | Dec 12, 2024 |
| D-0197-2025 | Class III | Diphenhydramine HCl 25 mg, 100 capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma… | Dec 12, 2024 |
| D-0196-2025 | Class III | Acetaminophen Extra Strength 500 mg, 1000 Tablets per bottle, Akron Pharma, Manufactured for: Akron… | Dec 12, 2024 |
| D-0195-2025 | Class III | Acetaminophen, 325 mg Tablets, 100 Tablets per bottle, Akron Pharma, Manufactured for: Akron Pharma… | Dec 12, 2024 |
| D-0199-2025 | Class III | Diphenhydramine HCl 50 mg, 1000 capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma… | Dec 12, 2024 |
| D-0193-2025 | Class III | Acetaminophen Extra Strength 500 mg, 100 Tablets per bottle, Akron Pharma, Inc., 373 RT US 46 W… | Dec 12, 2024 |
| D-0025-2025 | Class II | OneLAX Docusate Sodium Liquid (docusate sodium 50 mg/5 mL) Stool Softener Laxative, 16 FL OZ (473… | Oct 15, 2024 |
| D-0454-2023 | Class III | DIBUCAINE 1% HEMORRHOIDAL OINTMENT, 1 oz. (28 gm), Manufactured for: Akron Pharma Inc. Fairfield NJ… | Feb 17, 2023 |
| D-1353-2022 | Class III | Acetaminophen 500 mg tablet, Extra Strength, packaged in a) 100-count bottle (NDC 71399-8022-01), b)… | Aug 4, 2022 |
| D-1352-2022 | Class III | Acetaminophen 325 mg tablets, packaged in a) 100-count bottle (NDC 71399-8024-01); b) 1000-count… | Aug 4, 2022 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Aug 12, 2025 | Fairfield, NJ | Food/Cosmetics | No Action Indicated (NAI) | 3013943804 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3013943804 | Fairfield, NJ | 1 | Aug 12, 2025 |
Akron Pharma, Inc. and the FDA: common questions
Has Akron Pharma, Inc. received an FDA warning letter?
No FDA warning letter addressed to the name "Akron Pharma, Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Akron Pharma, Inc. received an FDA Form 483?
FDA has not published a Form 483 for "Akron Pharma, Inc." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Akron Pharma, Inc.?
The most recent FDA inspection on file ended Aug 12, 2025 at Fairfield, NJ and was classified NAI. FDA has 1 inspection of Akron Pharma, Inc. on file.
Has Akron Pharma, Inc. had an FDA recall?
Yes. Akron Pharma, Inc. has 11 FDA recalls on record. The most recent started Dec 12, 2024.
Need more than this page shows? Ask about Akron Pharma, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.